Future prospect of "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients"

被引：0
|
作者：
Kang, Yong-Bo [1 ]
Cai, Yue [1 ]
机构：
[1] Shanxi Med Univ, Dept Microbiol & Immunol, Sch Basic Med Sci, Wenhua St, Jinzhong 030600, Shanxi, Peoples R China
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2022年 / 28卷 / 20期
关键词：
Gut microbiome; Immunotherapy; Immune checkpoint inhibitor resistance; Probiotics; Faecal microbiota transplantation; Hepatocellular carcinoma; Prognosis;
D O I：
10.3748/wjg.v28.i20.2248
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Recently, we read the article "Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients" with interest, and it is preliminary suggested that gut microbiota is closely related to therapeutic effect of nivolumab. Based on the meaningful results of this article, several valuable research directions are proposed to enhance the therapeutic effect of immune checkpoint inhibitors on advanced hepatocellular carcinoma.
引用
收藏
页码：2248 / 2250
页数：3
相关论文
共 50 条
  • [21] Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
    Tella, Sri Harsha
    Mahipal, Amit
    Kommalapati, Anuhya
    Jin, Zhaohui
    ONCOTARGETS AND THERAPY, 2019, 12 : 10335 - 10342
  • [22] Different organ-specific response to nivolumab to determine the survival outcome of patients with advanced hepatocellular carcinoma (aHCC).
    Kim, Han Sang
    Hong, Jung Yong
    Cheon, Jaekyung
    Kim, Ilhwan
    Kim, Chang Gon
    Kang, Beodeul
    Kim, Dae Jung
    Kim, Chan
    Chon, Hongjae
    Choi, Hye Jin
    Lim, Ho Yeong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
    Mohieldeen, Khaled
    Hamoda, Soraya Abdel Fatah
    Ahmed, Shwikar Mahmoud
    Najeeb, Abdurrahman
    Ellakany, Walid Ismail
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [24] Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC).
    Gong, Jun
    Dizman, Nazli
    Poroyko, Valeriy
    Won, Haejung
    Bergerot, Cristiane Decat
    Bergerot, Paulo Gustavo
    Maia, Manuel C.
    Hsu, Joann
    Frankel, Paul Henry
    Jones, Jeremy
    Salgia, Ravi
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [25] Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
    Khaled Mohieldeen
    Soraya Abdel Fatah Hamoda
    Shwikar Mahmoud Ahmed
    Abdurrahman Najeeb
    Walid Ismail Ellakany
    Egyptian Liver Journal, 11
  • [26] Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
    Egerer, Mara
    Schuch, Kathrin
    Schoeler, David
    Artusa, Fabian
    Puengel, Tobias
    Holtman, Theresa Maria
    Loosen, Sven H.
    Demir, Muenevver
    Wree, Alexander
    Luedde, Tom
    Tacke, Frank
    Roderburg, Christoph
    Mohr, Raphael
    CANCERS, 2024, 16 (21)
  • [27] Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
    Shu-Guang Zhu
    Hai-Bo Li
    Ze-Nan Yuan
    Wei Liu
    Qing Yang
    Ying Cheng
    Wen-Jing Wang
    Guo-Ying Wang
    Hua Li
    World Journal of Gastrointestinal Oncology, 2020, (10) : 1209 - 1215
  • [28] Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
    Zhu, Shu-Guang
    Li, Hai-Bo
    Yuan, Ze-Nan
    Liu, Wei
    Yang, Qing
    Cheng, Ying
    Wang, Wen-Jing
    Wang, Guo-Ying
    Li, Hua
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (10) : 1209 - 1215
  • [29] The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19
    Martin-Castano, Benita
    Diez-Echave, Patricia
    Garcia-Garcia, Jorge
    Hidalgo-Garcia, Laura
    Ruiz-Malagon, Antonio Jesus
    Molina-Tijeras, Jose Alberto
    Rodriguez-Sojo, Maria Jesus
    Redruello-Romero, Anais
    Martinez-Zaldivar, Margarita
    Mota, Emilio
    Cobo, Fernando
    Diaz-Villamarin, Xando
    Alvarez-Estevez, Marta
    Garcia, Federico
    Morales-Garcia, Concepcion
    Merlos, Silvia
    Garcia-Flores, Paula
    Colmenero-Ruiz, Manuel
    Hernandez-Quero, Jose
    Nunez, Maria
    Rodriguez-Cabezas, Maria Elena
    Carazo, Angel
    Martin, Javier
    Moron, Rocio
    Nogales, Alba Rodriguez
    Galvez, Julio
    ELIFE, 2025, 13
  • [30] Can serum exosomal content predict response to immunotherapy in hepatocellular carcinoma
    Savaraj, Niramol
    Puente, Pablo
    Li, Ying-Ying
    Wu, Chunjing
    Nguyen, Jonathan D.
    Wangpaichitr, Medhi
    Hosein, Peter J.
    Feun, Lynn G.
    CANCER RESEARCH, 2024, 84 (06)
12345